Cyfuse Biomedical K.K. (TSE: 4892)
Health Care · Life Sciences Tools & Services · JP
¥622.00
-5.04% today · +6.5% 1Y
Cyfuse Biomedical K.K. (TSE: 4892) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $39.14M and employs 23 people.
Over the last twelve months the share price has gained 6.5%, trading between 487.00 and 764.00.
Tweenvest scores Cyfuse Biomedical K.K. across four factors: quality 40/100, value 66/100, growth 0/100. Its strongest factor is value.
4892 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.14M
- Revenue (TTM)
- $1.88M
- P/E
- —
- EPS
- -82.10
- Dividend yield
- —
- Beta (5Y)
- 1.27
- 52-week high
- ¥764.00
- 52-week low
- ¥487.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.96M
- Employees
- 23
- Next earnings
- —
About Cyfuse Biomedical K.K.
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
- ISIN
- JP3311800001
- Founded
- 2010
- Listed since
- Dec 1, 2022
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| QuadMedicine, Inc.KOSDAQ: A464490 | $41.08M | ₩4,810.00 | -6.60% |
| Cryosite LimitedASX: CTE | $41.04M | AU$1.21 | +4.78% |
| Precision System Science Co., Ltd.TSE: 7707 | $40.24M | ¥232.00 | +9.43% |
| WDB coco Co., Ltd.TSE: 7079 | $39.64M | ¥2,610.00 | -0.46% |
| CellSource Co., Ltd.TSE: 4880 | $38.99M | ¥311.00 | +1.30% |
| Arch Biopartners Inc.OTCPK: ACHF.F | $38.26M | $0.56 | -1.30% |
| Harvard Bioscience, Inc.NasdaqCM: HBIO | $37.51M | $8.49 | +3.03% |
| ORIENT BIO Inc.KOSE: A002630 | $36.12M | ₩1,638.00 | -0.12% |
Figures last refreshed Oct 11, 2026.